In a 56-page representation dated July 3, Zostel alleged that the draft red herring prospectus (DRHP) does not adequately capture the nature or potential commercial impact of the decade-old dispute between the two companies. It urged the market regulator to examine whether the disclosures provide investors with a complete and balanced picture before the company files its red herring prospectus.